Research map: What’s in a name? reframing advanced Parkinson’s disease as a multidimensional state
Back to the article
Papers in this map
Parkinsonism
· Margaret M. Maier Hoehn · 1967 · 12189 citations · Cited by this paper
Disease modification in advanced Parkinson’s disease: a review and roadmap for paving the way for next-generation interventions
· 2026 · Related
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results
· Christopher G. Goetz · 2008 · 7797 citations · Cited by this paper
Neuropsychiatric disorders in Parkinson’s disease
· 2025 · Related
Non-motor symptoms of Parkinson's disease: diagnosis and management
· К. Ray Chaudhuri · 2006 · 2814 citations · Cited by this paper
Beyond “Advanced”: proposing Fluctuation-Dominant Parkinson’s disease as a functional alternative to enable timely device-aided therapy
· 2026 · Related
Non-motor features of Parkinson disease
· Anthony H.V. Schapira · 2017 · 2093 citations · Cited by this paper
Early-Onset Parkinson’s Disease: Unique Features and Management Approaches
· 2025 · Related
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
· Klaus Seppi · 2019 · 1015 citations · Cited by this paper
Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care
· 2026 · Related
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
· Andrew D. Siderowf · 2023 · 746 citations · Cited by this paper
Optimizing Device-Aided Therapies in Advanced Parkinson’s Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios
· 2025 · Related
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
· Tanya Simuni · 2024 · 630 citations · Cited by this paper
The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation—a position paper
· 2026 · Related
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
· Günter U. Höglinger · 2024 · 549 citations · Cited by this paper
Digital Technologies for Symptom Monitoring in Parkinson Disease
· 2026 · Related
Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters
· Roberto Cilia · 2016 · 418 citations · Cited by this paper
Income, employment, and clinical outcomes in Parkinson’s disease
· 2026 · Related
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
· Kai Ma · 2018 · 382 citations · Cited by this paper
New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment
· 2026 · Related
Nonmotor fluctuations in Parkinson disease
· Alexander Storch · 2013 · 373 citations · Cited by this paper
Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review
· Meike Kasten · 2018 · 328 citations · Cited by this paper
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
· Nicolaas Ida Bohnen · 2010 · 321 citations · Cited by this paper
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach
· Angelo Antonini · 2018 · 281 citations · Cited by this paper
Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care
· Bastiaan R. Bloem · 2020 · 246 citations · Cited by this paper
Systematic review of hardware-related complications of Deep Brain Stimulation: Do new indications pose an increased risk?
· Onanong Jitkritsadakul · 2017 · 177 citations · Cited by this paper
Teaching tape for the motor section of the unified Parkinson's disease rating scale
· Christopher G. Goetz · 1995 · 154 citations · Cited by this paper
Artificial intelligence in neurodegenerative diseases: A review of available tools with a focus on machine learning techniques
· Alexandra-Maria Tăuţan · 2021 · 150 citations · Cited by this paper
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
· David C. Bäckström · 2020 · 148 citations · Cited by this paper
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
· Angeliki Zarkali · 2024 · 120 citations · Cited by this paper
Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson’s disease motor symptoms
· Anirudha S. Chandrabhatla · 2022 · 117 citations · Cited by this paper
Clinical Assessments in Parkinson's Disease
· Roongroj Bhidayasiri · 2017 · 106 citations · Cited by this paper
Autonomic Dysfunction in Parkinson's Disease
· Ronald F. Pfeiffer · 2020 · 105 citations · Cited by this paper
Consensus on the Definition of Advanced Parkinson’s Disease: A Neurologists-Based Delphi Study (CEPA Study)
· M. R. Luquín · 2017 · 104 citations · Cited by this paper
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers
· Gian D. Pal · 2022 · 104 citations · Cited by this paper
Deep Brain Stimulation and Cognitive Decline in Parkinson’s Disease: A Clinical Review
· João Massano · 2012 · 100 citations · Cited by this paper
Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature from 2017-2022
· Whitley W. Aamodt · 2023 · 99 citations · Cited by this paper
Digital biomarkers for precision diagnosis and monitoring in Parkinson’s disease
· Yue-meng Sun · 2024 · 96 citations · Cited by this paper
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic
· Shen‐Yang Lim · 2024 · 87 citations · Cited by this paper
Source: OpenAlex (CC0)